Expert Insights: Plexus Through the Lens of Four Analysts
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2025
0mins
Source: Benzinga
Analyst Ratings Overview: Plexus (NASDAQ: PLXS) received mixed ratings from 4 analysts over the past three months, with 3 bullish, 1 indifferent, and no bearish ratings. Recent evaluations show an upward trend in price targets, averaging $161.25, reflecting a 1.9% increase from the previous average.
Key Analyst Actions: Analysts have maintained or raised their ratings, with notable actions including David Williams and James Ricchiuti both raising their price targets to $165.00, indicating positive sentiment towards Plexus's performance.
Financial Performance Indicators: Plexus demonstrates strong financial health with a net margin of 4.86%, a return on equity (ROE) of 3.58%, and a return on assets (ROA) of 1.65%, all exceeding industry benchmarks. The company also maintains a low debt-to-equity ratio of 0.11, suggesting prudent debt management.
Company Profile: Plexus Corp is a U.S.-based Electronic Manufacturing Services company that offers a range of services from design to order fulfillment. It operates across various segments, including AMER, APAC, and EMEA, and has shown a revenue growth rate of 3.93% over the last three months.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PLXS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PLXS
Wall Street analysts forecast PLXS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PLXS is 157.50 USD with a low forecast of 150.00 USD and a high forecast of 165.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 180.850
Low
150.00
Averages
157.50
High
165.00
Current: 180.850
Low
150.00
Averages
157.50
High
165.00
About PLXS
Plexus Corp. is focused on providing designing and developing, supplying chain solutions, new product introduction, manufacturing and sustaining services. It specializes in serving customers in industries with complex products and demanding regulatory environments. It offers life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, and innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. Its segments include Americas (AMER), Asia-Pacific (APAC) and Europe, Middle East, and Africa (EMEA) regions. Its design and development capabilities include mechanical engineering, electrical engineering, software engineering, quality and compliance engineering, and project management. Its supply chain capabilities include design for supply chain, supply chain risk management, and managing global, and complex supply chains.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Plexus Corp. Reports Strong Q1 2026 Earnings and Positive Outlook
- Significant Revenue Growth: Plexus reported Q1 2026 revenue of $1.07 billion, meeting the midpoint of guidance and reflecting a robust 10% year-over-year increase, indicating strong performance across all market sectors and ongoing market share gains.
- Stable Gross Margin: The gross margin for Q1 was 9.9%, consistent with the previous quarter despite slight impacts from the opening of the new Malaysia facility, demonstrating the company's ability to maintain profitability during expansion.
- Optimistic Outlook: The company projects Q2 2026 revenue between $1.11 billion and $1.15 billion, representing a 6% sequential and 15% year-over-year growth, reflecting improved market demand and strong program wins.
- Increased Investment: Plexus raised its capital spending guidance for fiscal 2026 to $100 million to $120 million, aimed at supporting future revenue growth and operational efficiency, showcasing the company's confidence in long-term development.
Continue Reading
Plexus Scheduled to Announce Q1 Earnings on January 28
- Earnings Announcement Schedule: Plexus is set to release its Q1 earnings on January 28 after market close, with consensus EPS estimate at $1.73, flat year-over-year, and revenue expected at $1.07 billion, reflecting a 9.6% year-over-year growth, indicating resilience in the company's stable growth trajectory.
- Historical Performance: Over the past two years, Plexus has beaten EPS estimates 100% of the time, showcasing its earnings stability, although it has only exceeded revenue estimates 50% of the time, suggesting challenges in revenue growth.
- Expectation Revision Dynamics: In the last three months, EPS estimates have seen no upward revisions and three downward adjustments, while revenue estimates have experienced three upward revisions with none downward, reflecting increased market confidence in the company's future revenue growth but ongoing concerns regarding profitability.
- Market Focus: As the earnings report approaches, investors will closely monitor Plexus's performance, particularly in the current economic environment, as the company's profitability and revenue growth will directly impact its stock price performance.
Continue Reading